DGLRX
Price
$21.16
Change
+$0.14 (+0.67%)
Updated
Dec 24 closing price
RNPHX
Price
$62.90
Change
+$0.56 (+0.90%)
Updated
Dec 24 closing price
Ad is loading...

DGLRX vs RNPHX

Header iconDGLRX vs RNPHX Comparison
Open Charts DGLRX vs RNPHXBanner chart's image
BNY Mellon Global Stock - I
Price$21.16
Change+$0.14 (+0.67%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective R5E
Price$62.90
Change+$0.56 (+0.90%)
VolumeN/A
CapitalizationN/A
DGLRX vs RNPHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DGLRX vs. RNPHX commentary
Dec 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGLRX is a StrongBuy and RNPHX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RNPHX has more cash in the bank: 144B vs. DGLRX (913M). RNPHX pays higher dividends than DGLRX: RNPHX (1.00) vs DGLRX (0.37). DGLRX was incepted earlier than RNPHX: DGLRX (18 years) vs RNPHX (9 years). RNPHX is a more actively managed with annual turnover of: 17.00 vs. DGLRX (10.12). RNPHX has a lower initial minimum investment than DGLRX: RNPHX (250) vs DGLRX (1000). RNPHX annual gain was more profitable for investors over the last year : 15.23 vs. DGLRX (1.67). RNPHX return over 5 years is better than : 36.97 vs. DGLRX (-11.61).
DGLRXRNPHXDGLRX / RNPHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years9 years-
Gain YTD1.04014.5027%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets913M144B1%
Annual Yield % from dividends0.371.0037%
Returns for 1 year1.6715.2311%
Returns for 3 years-24.46-2.151,139%
Returns for 5 years-11.6136.97-31%
Returns for 10 years12.08N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARES181.062.06
+1.15%
Ares Management Corp
TUYA1.810.02
+1.12%
Tuya
AB36.800.31
+0.85%
AllianceBernstein Holding LP
ABTS0.45N/A
+0.67%
Abits Group
HRTX1.58-0.02
-1.25%
Heron Therapeutics